These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10362142)

  • 1. Expression of cytokeratin 19 mRNA in human lung cancer cell lines.
    Ueda Y; Fujita J; Bandoh S; Hojo S; Yamaji Y; Ohtsuki Y; Dobashi N; Takahara J
    Int J Cancer; 1999 Jun; 81(6):939-43. PubMed ID: 10362142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of caspase 3 in producing cytokeratin 19 fragment (CYFRA21-1) in human lung cancer cell lines.
    Dohmoto K; Hojo S; Fujita J; Yang Y; Ueda Y; Bandoh S; Yamaji Y; Ohtsuki Y; Dobashi N; Ishida T; Takahara J
    Int J Cancer; 2001 Feb; 91(4):468-73. PubMed ID: 11251967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of the release of CYFRA21-1 in human lung cancer cell lines.
    Dohmoto K; Hojo S; Fujita J; Ueda Y; Bandoh S; Yamaji Y; Ohtsuki Y; Dobashi N; Takahara J
    Lung Cancer; 2000 Oct; 30(1):55-63. PubMed ID: 11008010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cytokeratin 19 in human hepatocellular carcinoma cell lines.
    Wu F; Nishioka M; Fujita J; Murota M; Ohtsuki Y; Ishida T; Kuriyama S
    Int J Oncol; 2002 Jan; 20(1):31-7. PubMed ID: 11743639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of thyroid transcription factor-1 in 16 human lung cancer cell lines.
    Fujita J; Ohtsuki Y; Bandoh S; Ueda Y; Kubo A; Tojo Y; Yamaji Y; Ishida T
    Lung Cancer; 2003 Jan; 39(1):31-6. PubMed ID: 12499091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cytokeratin 8 in lung cancer cell lines and measurement of serum cytokeratin 8 in lung cancer patients.
    Fukunaga Y; Bandoh S; Fujita J; Yang Y; Ueda Y; Hojo S; Dohmoto K; Tojo Y; Takahara J; Ishida T
    Lung Cancer; 2002 Oct; 38(1):31-8. PubMed ID: 12367790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The point mutation in the promoter region and the single nucleotide polymorphism in exon 1 of the cytokeratin 19 gene in human lung cancer cell lines.
    Fujita J; Dohmoto K; Hojo S; Ueda Y; Bandoh S; Yang Y; Yamaji Y; Ohtsuki Y; Ishida T
    Lung Cancer; 2001 Dec; 34(3):387-94. PubMed ID: 11714536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Message RNA expression of LUNX, CK19 and CEA genes in NSCLC with micrometastasis in lymph nodes].
    Wang WB; Cui YG; Yao SY
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):121-4. PubMed ID: 18646695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells.
    Ruud P; Fodstad O; Hovig E
    Int J Cancer; 1999 Jan; 80(1):119-25. PubMed ID: 9935241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-time RT-PCR detection of CK19, CK7 and MUC1 mRNA for diagnosis of lymph node micrometastases in non small cell lung carcinoma.
    Saintigny P; Coulon S; Kambouchner M; Ricci S; Martinot E; Danel C; Breau JL; Bernaudin JF
    Int J Cancer; 2005 Jul; 115(5):777-82. PubMed ID: 15729695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant messenger RNA splicing of the cytokeratin 8 in lung cancer.
    Tojo Y; Bandoh S; Fujita J; Kubo A; Ishii T; Fukunaga Y; Ueda Y; Yang Y; Wu F; Huang CL; Yokomise H; Ishida T
    Lung Cancer; 2003 Nov; 42(2):153-61. PubMed ID: 14568682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplex PCR-based detection of circulating tumor cells in lung cancer patients using CK19, PTHrP, and LUNX specific primers.
    Katseli A; Maragos H; Nezos A; Syrigos K; Koutsilieris M
    Clin Lung Cancer; 2013 Sep; 14(5):513-20. PubMed ID: 23810363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: an independent prognostic factor.
    Chen TF; Jiang GL; Fu XL; Wang LJ; Qian H; Wu KL; Zhao S
    Lung Cancer; 2007 Apr; 56(1):105-14. PubMed ID: 17166620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling of cultured human bronchial epithelial and lung carcinoma cells.
    Hellmann GM; Fields WR; Doolittle DJ
    Toxicol Sci; 2001 May; 61(1):154-63. PubMed ID: 11294986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low specificity of cytokeratin 19 mRNA expression in the peripheral blood cells from patients with ovarian tumors.
    Takano H; Okamoto A; Fukushima K; Ochiai K; Tanaka T
    Oncol Rep; 2000; 7(5):1023-5. PubMed ID: 10948333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Levels of cytokeratin CK19 expression in mononuclear blood cells evaluated using a reverse PCR (RT-PCR)].
    López Guerrero JA; Bolufer P; Barragán E; Sanz Alonso M; Palau J; Sempere A; De la Rubia J; Bonanad S; Torregrosa MD
    Sangre (Barc); 1996 Dec; 41(6):441-6. PubMed ID: 9148421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers.
    Suzuki M; Shigematsu H; Shames DS; Sunaga N; Takahashi T; Shivapurkar N; Iizasa T; Minna JD; Fujisawa T; Gazdar AF
    Ann Surg Oncol; 2007 Apr; 14(4):1397-404. PubMed ID: 17195088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased fragile histidine triad gene messenger RNA expression in lung cancer.
    Sasaki H; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    Clin Lung Cancer; 2006 May; 7(6):412-6. PubMed ID: 16800968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative correlation of cytokeratin 19 mRNA level in peripheral blood with disease stage and metastasis in breast cancer patients: potential prognostic implications.
    Wong IH; Yeo W; Chan AT; Johnson PJ
    Int J Oncol; 2001 Mar; 18(3):633-8. PubMed ID: 11179498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced transcription of the RB2/p130 gene in human lung cancer.
    Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
    Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.